191 related articles for article (PubMed ID: 3306360)
21. Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.
Clark SS; McLaughlin J; Crist WM; Champlin R; Witte ON
Science; 1987 Jan; 235(4784):85-8. PubMed ID: 3541203
[TBL] [Abstract][Full Text] [Related]
22. Translocation of c-abl oncogene and PDGFB (c-sis) gene in a case of CML with 46,XY, t(22;22).
Gradl G; Tesch H; Schwieder G; Wagner T; Fonatsch C
Blut; 1989 Jun; 58(6):279-85. PubMed ID: 2660925
[TBL] [Abstract][Full Text] [Related]
23. Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia.
Zagaria A; Anelli L; Albano F; Vicari L; Schiavone EM; Annunziata M; Pane F; Liso V; Rocchi M; Specchia G
Cancer Genet Cytogenet; 2006 Jun; 167(2):97-102. PubMed ID: 16737907
[TBL] [Abstract][Full Text] [Related]
24. Molecular biology of the Philadelphia positive leukaemias.
Morgan GJ; Wiedemann LM
Recenti Prog Med; 1989 Oct; 80(10):508-19. PubMed ID: 2690217
[TBL] [Abstract][Full Text] [Related]
25. Molecular biology of chronic myelogenous leukemia.
Dreazen O; Canaani E; Gale RP
Semin Hematol; 1988 Jan; 25(1):35-48. PubMed ID: 3279514
[TBL] [Abstract][Full Text] [Related]
26. Fusion of the bcr and the c-abl genes in Ph'-positive acute lymphocytic leukemia with no rearrangement in the breakpoint cluster region.
ar-Rushdi A; Negrini M; Kurzrock R; Huebner K; Croce CM
Oncogene; 1988 Apr; 2(4):353-7. PubMed ID: 3283653
[TBL] [Abstract][Full Text] [Related]
27. Long-range mapping of the Philadelphia chromosome by pulsed-field gel electrophoresis.
Westbrook CA; Rubin CM; Carrino JJ; Le Beau MM; Bernards A; Rowley JD
Blood; 1988 Mar; 71(3):697-702. PubMed ID: 3422829
[TBL] [Abstract][Full Text] [Related]
28. Ph1+bcr- acute leukemias: implication of Alu sequences in a chromosomal translocation occurring in the new cluster region within the BCR gene.
Chen SJ; Chen Z; d'Auriol L; Le Coniat M; Grausz D; Berger R
Oncogene; 1989 Feb; 4(2):195-202. PubMed ID: 2648256
[TBL] [Abstract][Full Text] [Related]
29. Persistence of chronic myelocytic leukemia despite deletion of rearranged bcr/c-abl sequences in blast crisis.
Bartram CR; Janssen JW; Becher R; de Klein A; Grosveld G
J Exp Med; 1986 Nov; 164(5):1389-96. PubMed ID: 3464689
[TBL] [Abstract][Full Text] [Related]
30. Oncogene activation by chromosomal translocation in chronic myelocytic leukemia.
Groffen J; Heisterkamp N; Stam K
Cold Spring Harb Symp Quant Biol; 1986; 51 Pt 2():911-21. PubMed ID: 3472767
[No Abstract] [Full Text] [Related]
31. Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.
Konopka JB; Clark S; McLaughlin J; Nitta M; Kato Y; Strife A; Clarkson B; Witte ON
Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4049-52. PubMed ID: 3012546
[TBL] [Abstract][Full Text] [Related]
32. Mapping of four distinct BCR-related loci to chromosome region 22q11: order of BCR loci relative to chronic myelogenous leukemia and acute lymphoblastic leukemia breakpoints.
Croce CM; Huebner K; Isobe M; Fainstain E; Lifshitz B; Shtivelman E; Canaani E
Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7174-8. PubMed ID: 3118359
[TBL] [Abstract][Full Text] [Related]
33. Molecular insights into the Philadelphia translocation.
Heisterkamp N; Groffen J
Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
[TBL] [Abstract][Full Text] [Related]
34. Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome.
Mes-Masson AM; McLaughlin J; Daley GQ; Paskind M; Witte ON
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9768-72. PubMed ID: 3540951
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning and serological characterization of an altered c-abl gene product produced in Ph1 CML patients.
Mes-Masson AM; McLaughlin J; Witte O
Haematol Blood Transfus; 1987; 31():163-6. PubMed ID: 3127280
[TBL] [Abstract][Full Text] [Related]
36. Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia.
Grossman A; Silver RT; Arlin Z; Coleman M; Camposano E; Gascon P; Benn PA
Am J Hum Genet; 1989 Nov; 45(5):729-38. PubMed ID: 2683759
[TBL] [Abstract][Full Text] [Related]
37. C-abl and bcr are rearranged in a Ph1-negative CML patient.
Bartram CR; Kleihauer E; de Klein A; Grosveld G; Teyssier JR; Heisterkamp N; Groffen J
EMBO J; 1985 Mar; 4(3):683-6. PubMed ID: 3859408
[TBL] [Abstract][Full Text] [Related]
38. Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisis.
Collins SJ
J Clin Invest; 1986 Nov; 78(5):1392-6. PubMed ID: 3021820
[TBL] [Abstract][Full Text] [Related]
39. Negative regulation of p120GAP GTPase promoting activity by p210bcr/abl: implication for RAS-dependent Philadelphia chromosome positive cell growth.
Skorski T; Kanakaraj P; Ku DH; Nieborowska-Skorska M; Canaani E; Zon G; Perussia B; Calabretta B
J Exp Med; 1994 Jun; 179(6):1855-65. PubMed ID: 8195713
[TBL] [Abstract][Full Text] [Related]
40. Transposition of c-abl oncogene in a case of masked Ph chromosome duplicated in blastic phase.
Maserati E; Cavalli P; Casalone R; Morandi S; Pasquali F
Hum Genet; 1988 Mar; 78(3):248-50. PubMed ID: 3162225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
